Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 230 participants.

Also called NCT04583462

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 230 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04583462
  • EudraCT 2018-003121-29
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04583462. Randomized; quadruple masking; primary purpose prevention. Start 2021-06-02 (actual); primary completion 2027-09-29 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes
Acronym
IMPACT-1D
Condition
Type 1 Diabetes
Condition
Peripheral Arterial Calcification
Intervention (Drug)
Metformin
Intervention (Drug)
Placebo
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)

Record details

Record id
cardio:ct-nct04583462
Content hash
685dd3bbfc9a6de1e0b7f6b5be054e69b177ebf7659a5d148527938606c77cbe